tiprankstipranks
Mersana Therapeutics transferred with Buy rating at Citi
PremiumThe FlyMersana Therapeutics transferred with Buy rating at Citi
2M ago
Mersana Therapeutics Reports Q3 2024 Financial Results
Premium
Company Announcements
Mersana Therapeutics Reports Q3 2024 Financial Results
2M ago
Mersana Therapeutics Reports Progress in Cancer Treatments
Premium
Company Announcements
Mersana Therapeutics Reports Progress in Cancer Treatments
2M ago
Mersana Therapeutics Releases Updated Corporate Presentation
PremiumCompany AnnouncementsMersana Therapeutics Releases Updated Corporate Presentation
5M ago
Mersana Therapeutics sees cash runway into 2026
Premium
The Fly
Mersana Therapeutics sees cash runway into 2026
5M ago
Mersana Therapeutics reports Q2 EPS (20c), consensus (17c)
Premium
The Fly
Mersana Therapeutics reports Q2 EPS (20c), consensus (17c)
5M ago
Mersana Therapeutics upgraded to Neutral from Underweight at JPMorgan
PremiumThe FlyMersana Therapeutics upgraded to Neutral from Underweight at JPMorgan
10M ago
Wedbush bullish on Mersana Therapeutics, upgrades to Outperform
Premium
The Fly
Wedbush bullish on Mersana Therapeutics, upgrades to Outperform
11M ago
Mersana Therapeutics upgraded to Buy from Hold at Truist
Premium
The Fly
Mersana Therapeutics upgraded to Buy from Hold at Truist
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100